Original language | English (US) |
---|---|
Pages (from-to) | 481-482 |
Number of pages | 2 |
Journal | Science |
Volume | 383 |
Issue number | 6682 |
DOIs | |
State | Published - Feb 20 2024 |
Funding
J.R.W. has advised or received clinical research support from Abbvie, ADC Therapeutics, AstraZeneca, Bristol-Myers Squibb, Genentech, GenMab, Kite, Janssen, Kymera, Merck, Morphosys/Incyte, Novartis, Regeneron, and SeaGen.
ASJC Scopus subject areas
- General